Human Albumin Grifols Solution
NDC Package 61953-0001-2
Package Information
Human Albumin Grifols (albumin (human)) solution is hypersensitivity to albumin preparations or to any of the excipients.Severe anemia or cardiac failure with normal or increased intravascular volume. This formulation utilizes a solution delivery system. Marketed by Grifols Usa, Llc, this product is identified by NDC 61953-0001 and is authorized under FDA application BLA103352.
Identification & Billing
- RxCUI: 1741295 - albumin human 20 % in 100 ML Injection
- RxCUI: 1741295 - 100 ML albumin human, USP 200 MG/ML Injection
- RxCUI: 1741295 - albumin human 20 % per 100 ML Injection
- RxCUI: 1741295 - albumin human 20 GM per 100 ML Injection
- RxCUI: 1741304 - Human Albumin Grifols 20 % in 100 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 61953 - Grifols Usa, Llc
- 61953-0001 - Human Albumin Grifols
- 61953-0001-2 - 1 VIAL in 1 CARTON / 100 mL in 1 VIAL (61953-0001-4)
- 61953-0001 - Human Albumin Grifols
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 61953-0001-2 identifies a specific commercial package of 1 vial in 1 carton / 100 ml in 1 vial (61953-0001-4) of Human Albumin Grifols, a plasma derivative labeled by Grifols Usa, Llc. This solution is formulated for intravenous use and contains albumin human as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Grifols Usa, Llc on February 17, 1995. The current certification is valid through December 31, 2026.
How is this Grifols Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 61953000102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.